Other International projects

IDIBAPS/FCRB also receive funding by other entities from abroad that launch competitive calls for funding. Such entities are usually charities, foundations or private companies.

Discovering the Partners of PCSK9 in Hepatic Endosomes: The Where, How, and Why of PCSK9 in Atherosclerosis.

PI: POL SOROLLA, ALBERTO
Funding: AMGEN
Beneficiary organization: IDIBAPS
Reference: PCSK9_001
Amount: 160,564.84 €
Duration: 01/09/2018 to 31/08/2020

Targeting the HER2-enriched phenotype in hormone receptor-positive breast cancer

PI: PRAT APARICIO, ALEIX
Funding: Breast Cancer Now
Beneficiary organization: IDIBAPS
Reference: 2018NOVPCC1294
Amount: 320,878 €
Duration: 01/03/2019 to 28/02/2022

Financial Support for the Breast Cancer Intergroup Correlative Science Studies

PI: PRAT APARICIO, ALEIX
Funding: Regents of the University of Michigan
Beneficiary organization: FUNDACIO CLINIC
Reference: INT_BCRF_2015_01
Amount: 50,001 €
Duration: 01/10/2014 to 30/09/2019

Melanoma Survival Model of genetic variant involved in naevus count

PI: PUIG SARDA, SUSANA
Funding: European Academy of Dermatology and Venereology
Beneficiary organization: IDIBAPS
Reference: PPRC-2017-19
Amount: 100,000 €
Duration: 01/01/2018 to 31/12/2019

Direct reprogramming of human fibroblasts towards insulin-producing cells

PI: GASA ARNALDICH, ROSA MARIA
Funding: EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES
Beneficiary organization: IDIBAPS
Reference: EFSD_GASA_17_001
Amount: 100,000 €
Duration: 01/01/2018 to 31/12/2019

Mitochondrial fusion in endothelial cells: impact on systemic energy and glucose homeostasis

PI: CLARET CARLES, MARC
Funding: EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES
Beneficiary organization: IDIBAPS
Reference: EFSD/NOVO_17_01
Amount: 99,880 €
Duration: 15/02/2018 to 14/02/2020

Capillarization of the liver sinusoidal endothelium: Orchestration by miRNAs

PI: GRACIA SANCHO, JORDI
Funding: GILEAD SCIENCES
Beneficiary organization: IDIBAPS
Reference: GILEAD_IRS_16_02
Amount: 101,000 €
Duration: 02/08/2016 to 01/08/2019

Defining the best strategy for global HCV screening, linkage-to-care education and prevention in PWID population and validation of a new diagnostic dried blood spot test.

PI: LENS GARCIA, SABELA
Funding: GILEAD SCIENCES
Beneficiary organization: IDIBAPS
Reference: IN-ES-987-5349
Amount: 284,089 €
Duration: 01/12/2018 to 30/11/2020

Antigen-specific therapy in patients with NMO treated with tolerated autologous dendritic cells (Phase 1b clinical trial)

PI: BLANCO MORGADO, YOLANDA
Funding: THE GUTHY-JACKSON CHARITABLE FOUNDATION
Beneficiary organization: FUNDACIO CLINIC
Amount: 131,877 €
Duration: 01/08/2018 to 31/12/2019

Nanomedicines to expand type 1 diabetesspecific T-regulatory-1 type cells: mechanistic and translational studies

PI: SERRA DEVECCHI, PABLO
Funding: JUVENILE DIABETES RES.FOUNDATION
Beneficiary organization: IDIBAPS
Reference: 5-CDA-2014-214-A-N
Amount: 505,998.63 €
Duration: 01/06/2014 to 31/05/2019

Retinal molecular imaging in MS by Raman Spectroscopy to quantify inflammatory and neurodegenerative activity in MS

PI: HERNANDEZ MARTINEZ DE LAPISCINA, ELENA
Funding: MERCK KGaA Account Payable
Beneficiary organization: IDIBAPS
Reference: MERCKSER_GMSI_16_01
Amount: 249,980 €
Duration: 01/11/2016 to 31/10/2019

MicroRNAs AS BIOMARKERS OF THE PRODROMAL STAGE OF PARKINSON DISEASE. Expansion of microRNA findings to Ashkenazi Jew PD Cohorts

PI: EZQUERRA TRABALON, MARIO
Funding: Michael J. Fox Foundation for Parkinson
Beneficiary organization: IDIBAPS
Reference: 11159.01
Amount: 179,680.43 €
Duration: 08/06/2018 to 07/12/2019

EPIGENETIC REGULATION OF BDNF EXPRESSION ACCORDING TO RESPONSE TO COGNITIVE REMEDIATION IN SCHIZOPHRENIA

PI: PENADES RUBIO, RAFAEL
Funding: NARSAD
Beneficiary organization: IDIBAPS
Reference: NARSAD16_IIG_002
Amount: 36,666.33 €
Duration: 15/09/2016 to 14/09/2019

From the synapse to brain structure and function: a comparative study between youth with early stage psychosis and patients with NMDA Receptro Encephalitis

PI: SUGRANYES ERNEST, GISELA
Funding: NARSAD
Beneficiary organization: IDIBAPS
Reference: NARSAD17_YIG_02B
Amount: 57,763.65 €
Duration: 15/02/2018 to 14/02/2020